Monte Rosa raises $96M Series B for drug development platform technology
The Boston-based company plans to develop small-molecule therapeutics that go after historically "undruggable" targets using a process known as protein degradation.
BridgeBio Pharma raises $299.2M in financing round
The company sources product candidates from academic and commercial research and then launches subsidiary companies to develop them.
presented by
The Top 5 Home Care Franchise Opportunities in the U.S.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
Atreca raises $125M in oversubscribed Series C funding round
The California-based drugmaker plans to use the money to advance its investigational drugs with MOAs based on immune system responses.
Spirox closes $45M Series C for its device used by Ear, Nose and Throat physicians
Nasal obstruction is a significant problem that effects more than three million Americans each year. Spirox is developing a minimally invasive device that would decrease the need for surgery.
Aisling Capital launching fourth, $400M life sciences fund
The private equity firm's fourth fund has a hard cap of $500 million. It has a vast portfolio in the life sciences, including Cidara Therapeutics, T2 Biosystems and Seragon Pharmaceuticals.